Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF
Gespeichert in:
| Veröffentlicht in: | Leukemia 2024-04, Vol.38 (4), p.893-897 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 897 |
|---|---|
| container_issue | 4 |
| container_start_page | 893 |
| container_title | Leukemia |
| container_volume | 38 |
| creator | Žáčková, Daniela Semerád, Lukáš Faber, Edgar Klamová, Hana Stejskal, Lukáš Bělohlávková, Petra Karas, Michal Cmunt, Eduard Černá, Olga Procházková, Jiřina Čičátková, Petra Kvetková, Anežka Horňák, Tomáš Skoumalová, Ivana Srbová, Dana Šálek, Cyril Buffa, David Voglová, Jaroslava Jurček, Tomáš Folta, Adam Ježíšková, Ivana Žižková, Hana Machová Poláková, Kateřina Papajík, Tomáš Žák, Pavel Jindra, Pavel Svobodník, Adam Štěpánová, Radka Mayer, Jiří |
| description | |
| doi_str_mv | 10.1038/s41375-024-02215-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10997522</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2956681986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-bd1b738065d5d0c22d9c4761a93480f5fd465d942bcbeed02c472627b1e5b34a3</originalsourceid><addsrcrecordid>eNp9Ustu1DAUjRCIDoUfYIGuxIZNwHbsPFbVaERpxUhsilhaTnJn4taxg-1QDb_Wn6tnppTHgoVlWedxfY9Olr2m5D0lRf0hcFpUIieMp8OoyJsn2YLyqsyFEPRptiB1XeVlw_hJ9iKEa0L2YPk8OylqXjFe1Yvs7tuwA-URrIugjAE0eqtbg9AN3lndwbhD43QPBucbHLWCSUWNNga41cZou4XoQMWI4xQh7rwL2iLcaKsCgraDbnV0HnodOmejtnOSO3sGS1j9xG4Ae3jf6h5BWWV2QQfwaFTEfu8cB4Srz5cQopumwzSvlYGL5fr8ZfZso0zAVw_3afb1_OPV6iJff_l0uVqu846zMuZtT9uqqEkpetGTjrG-6VIOVDUFr8lGbHqeoIaztmsRe8ISykpWtRRFW3BVnGZnR99pbkfsu7S8V0ZOXo_K76RTWv6NWD3IrfshKWmaSjCWHN49OHj3fcYQ5ZjiQGOURTcHyRpRljVt6jJR3_5DvXazT8EEWZCiqHjJBU8sdmR1Ke_gcfP4G0rkvhzyWA6ZyiEP5ZBNEr35c49Hya82JEJxJIQE2S3637P_Y3sPc4bJ5w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3033746454</pqid></control><display><type>article</type><title>Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF</title><source>SpringerLink Journals - AutoHoldings</source><creator>Žáčková, Daniela ; Semerád, Lukáš ; Faber, Edgar ; Klamová, Hana ; Stejskal, Lukáš ; Bělohlávková, Petra ; Karas, Michal ; Cmunt, Eduard ; Černá, Olga ; Procházková, Jiřina ; Čičátková, Petra ; Kvetková, Anežka ; Horňák, Tomáš ; Skoumalová, Ivana ; Srbová, Dana ; Šálek, Cyril ; Buffa, David ; Voglová, Jaroslava ; Jurček, Tomáš ; Folta, Adam ; Ježíšková, Ivana ; Žižková, Hana ; Machová Poláková, Kateřina ; Papajík, Tomáš ; Žák, Pavel ; Jindra, Pavel ; Svobodník, Adam ; Štěpánová, Radka ; Mayer, Jiří</creator><creatorcontrib>Žáčková, Daniela ; Semerád, Lukáš ; Faber, Edgar ; Klamová, Hana ; Stejskal, Lukáš ; Bělohlávková, Petra ; Karas, Michal ; Cmunt, Eduard ; Černá, Olga ; Procházková, Jiřina ; Čičátková, Petra ; Kvetková, Anežka ; Horňák, Tomáš ; Skoumalová, Ivana ; Srbová, Dana ; Šálek, Cyril ; Buffa, David ; Voglová, Jaroslava ; Jurček, Tomáš ; Folta, Adam ; Ježíšková, Ivana ; Žižková, Hana ; Machová Poláková, Kateřina ; Papajík, Tomáš ; Žák, Pavel ; Jindra, Pavel ; Svobodník, Adam ; Štěpánová, Radka ; Mayer, Jiří</creatorcontrib><identifier>ISSN: 0887-6924</identifier><identifier>ISSN: 1476-5551</identifier><identifier>EISSN: 1476-5551</identifier><identifier>DOI: 10.1038/s41375-024-02215-9</identifier><identifier>PMID: 38472478</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699/1541/1990/283/1896 ; 692/700/784 ; Cancer Research ; Chronic myeloid leukemia ; Critical Care Medicine ; Drug dosages ; Education ; Elementary schools ; Females ; Hematology ; Intensive ; Internal Medicine ; Kinases ; Letter ; Leukemia ; Medicine ; Medicine & Public Health ; Multivariate analysis ; Myeloid leukemia ; Oncology ; Remission (Medicine) ; Tyrosine ; Tyrosine kinase inhibitors</subject><ispartof>Leukemia, 2024-04, Vol.38 (4), p.893-897</ispartof><rights>The Author(s) 2024</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c426t-bd1b738065d5d0c22d9c4761a93480f5fd465d942bcbeed02c472627b1e5b34a3</cites><orcidid>0000-0002-8415-7069 ; 0000-0002-7003-3372 ; 0000-0003-0567-9887 ; 0000-0001-9802-8148 ; 0000-0002-0021-3247</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41375-024-02215-9$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41375-024-02215-9$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38472478$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Žáčková, Daniela</creatorcontrib><creatorcontrib>Semerád, Lukáš</creatorcontrib><creatorcontrib>Faber, Edgar</creatorcontrib><creatorcontrib>Klamová, Hana</creatorcontrib><creatorcontrib>Stejskal, Lukáš</creatorcontrib><creatorcontrib>Bělohlávková, Petra</creatorcontrib><creatorcontrib>Karas, Michal</creatorcontrib><creatorcontrib>Cmunt, Eduard</creatorcontrib><creatorcontrib>Černá, Olga</creatorcontrib><creatorcontrib>Procházková, Jiřina</creatorcontrib><creatorcontrib>Čičátková, Petra</creatorcontrib><creatorcontrib>Kvetková, Anežka</creatorcontrib><creatorcontrib>Horňák, Tomáš</creatorcontrib><creatorcontrib>Skoumalová, Ivana</creatorcontrib><creatorcontrib>Srbová, Dana</creatorcontrib><creatorcontrib>Šálek, Cyril</creatorcontrib><creatorcontrib>Buffa, David</creatorcontrib><creatorcontrib>Voglová, Jaroslava</creatorcontrib><creatorcontrib>Jurček, Tomáš</creatorcontrib><creatorcontrib>Folta, Adam</creatorcontrib><creatorcontrib>Ježíšková, Ivana</creatorcontrib><creatorcontrib>Žižková, Hana</creatorcontrib><creatorcontrib>Machová Poláková, Kateřina</creatorcontrib><creatorcontrib>Papajík, Tomáš</creatorcontrib><creatorcontrib>Žák, Pavel</creatorcontrib><creatorcontrib>Jindra, Pavel</creatorcontrib><creatorcontrib>Svobodník, Adam</creatorcontrib><creatorcontrib>Štěpánová, Radka</creatorcontrib><creatorcontrib>Mayer, Jiří</creatorcontrib><title>Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF</title><title>Leukemia</title><addtitle>Leukemia</addtitle><addtitle>Leukemia</addtitle><subject>692/699/1541/1990/283/1896</subject><subject>692/700/784</subject><subject>Cancer Research</subject><subject>Chronic myeloid leukemia</subject><subject>Critical Care Medicine</subject><subject>Drug dosages</subject><subject>Education</subject><subject>Elementary schools</subject><subject>Females</subject><subject>Hematology</subject><subject>Intensive</subject><subject>Internal Medicine</subject><subject>Kinases</subject><subject>Letter</subject><subject>Leukemia</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Multivariate analysis</subject><subject>Myeloid leukemia</subject><subject>Oncology</subject><subject>Remission (Medicine)</subject><subject>Tyrosine</subject><subject>Tyrosine kinase inhibitors</subject><issn>0887-6924</issn><issn>1476-5551</issn><issn>1476-5551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><recordid>eNp9Ustu1DAUjRCIDoUfYIGuxIZNwHbsPFbVaERpxUhsilhaTnJn4taxg-1QDb_Wn6tnppTHgoVlWedxfY9Olr2m5D0lRf0hcFpUIieMp8OoyJsn2YLyqsyFEPRptiB1XeVlw_hJ9iKEa0L2YPk8OylqXjFe1Yvs7tuwA-URrIugjAE0eqtbg9AN3lndwbhD43QPBucbHLWCSUWNNga41cZou4XoQMWI4xQh7rwL2iLcaKsCgraDbnV0HnodOmejtnOSO3sGS1j9xG4Ae3jf6h5BWWV2QQfwaFTEfu8cB4Srz5cQopumwzSvlYGL5fr8ZfZso0zAVw_3afb1_OPV6iJff_l0uVqu846zMuZtT9uqqEkpetGTjrG-6VIOVDUFr8lGbHqeoIaztmsRe8ISykpWtRRFW3BVnGZnR99pbkfsu7S8V0ZOXo_K76RTWv6NWD3IrfshKWmaSjCWHN49OHj3fcYQ5ZjiQGOURTcHyRpRljVt6jJR3_5DvXazT8EEWZCiqHjJBU8sdmR1Ke_gcfP4G0rkvhzyWA6ZyiEP5ZBNEr35c49Hya82JEJxJIQE2S3637P_Y3sPc4bJ5w</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Žáčková, Daniela</creator><creator>Semerád, Lukáš</creator><creator>Faber, Edgar</creator><creator>Klamová, Hana</creator><creator>Stejskal, Lukáš</creator><creator>Bělohlávková, Petra</creator><creator>Karas, Michal</creator><creator>Cmunt, Eduard</creator><creator>Černá, Olga</creator><creator>Procházková, Jiřina</creator><creator>Čičátková, Petra</creator><creator>Kvetková, Anežka</creator><creator>Horňák, Tomáš</creator><creator>Skoumalová, Ivana</creator><creator>Srbová, Dana</creator><creator>Šálek, Cyril</creator><creator>Buffa, David</creator><creator>Voglová, Jaroslava</creator><creator>Jurček, Tomáš</creator><creator>Folta, Adam</creator><creator>Ježíšková, Ivana</creator><creator>Žižková, Hana</creator><creator>Machová Poláková, Kateřina</creator><creator>Papajík, Tomáš</creator><creator>Žák, Pavel</creator><creator>Jindra, Pavel</creator><creator>Svobodník, Adam</creator><creator>Štěpánová, Radka</creator><creator>Mayer, Jiří</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8415-7069</orcidid><orcidid>https://orcid.org/0000-0002-7003-3372</orcidid><orcidid>https://orcid.org/0000-0003-0567-9887</orcidid><orcidid>https://orcid.org/0000-0001-9802-8148</orcidid><orcidid>https://orcid.org/0000-0002-0021-3247</orcidid></search><sort><creationdate>20240401</creationdate><title>Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF</title><author>Žáčková, Daniela ; Semerád, Lukáš ; Faber, Edgar ; Klamová, Hana ; Stejskal, Lukáš ; Bělohlávková, Petra ; Karas, Michal ; Cmunt, Eduard ; Černá, Olga ; Procházková, Jiřina ; Čičátková, Petra ; Kvetková, Anežka ; Horňák, Tomáš ; Skoumalová, Ivana ; Srbová, Dana ; Šálek, Cyril ; Buffa, David ; Voglová, Jaroslava ; Jurček, Tomáš ; Folta, Adam ; Ježíšková, Ivana ; Žižková, Hana ; Machová Poláková, Kateřina ; Papajík, Tomáš ; Žák, Pavel ; Jindra, Pavel ; Svobodník, Adam ; Štěpánová, Radka ; Mayer, Jiří</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-bd1b738065d5d0c22d9c4761a93480f5fd465d942bcbeed02c472627b1e5b34a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>692/699/1541/1990/283/1896</topic><topic>692/700/784</topic><topic>Cancer Research</topic><topic>Chronic myeloid leukemia</topic><topic>Critical Care Medicine</topic><topic>Drug dosages</topic><topic>Education</topic><topic>Elementary schools</topic><topic>Females</topic><topic>Hematology</topic><topic>Intensive</topic><topic>Internal Medicine</topic><topic>Kinases</topic><topic>Letter</topic><topic>Leukemia</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Multivariate analysis</topic><topic>Myeloid leukemia</topic><topic>Oncology</topic><topic>Remission (Medicine)</topic><topic>Tyrosine</topic><topic>Tyrosine kinase inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Žáčková, Daniela</creatorcontrib><creatorcontrib>Semerád, Lukáš</creatorcontrib><creatorcontrib>Faber, Edgar</creatorcontrib><creatorcontrib>Klamová, Hana</creatorcontrib><creatorcontrib>Stejskal, Lukáš</creatorcontrib><creatorcontrib>Bělohlávková, Petra</creatorcontrib><creatorcontrib>Karas, Michal</creatorcontrib><creatorcontrib>Cmunt, Eduard</creatorcontrib><creatorcontrib>Černá, Olga</creatorcontrib><creatorcontrib>Procházková, Jiřina</creatorcontrib><creatorcontrib>Čičátková, Petra</creatorcontrib><creatorcontrib>Kvetková, Anežka</creatorcontrib><creatorcontrib>Horňák, Tomáš</creatorcontrib><creatorcontrib>Skoumalová, Ivana</creatorcontrib><creatorcontrib>Srbová, Dana</creatorcontrib><creatorcontrib>Šálek, Cyril</creatorcontrib><creatorcontrib>Buffa, David</creatorcontrib><creatorcontrib>Voglová, Jaroslava</creatorcontrib><creatorcontrib>Jurček, Tomáš</creatorcontrib><creatorcontrib>Folta, Adam</creatorcontrib><creatorcontrib>Ježíšková, Ivana</creatorcontrib><creatorcontrib>Žižková, Hana</creatorcontrib><creatorcontrib>Machová Poláková, Kateřina</creatorcontrib><creatorcontrib>Papajík, Tomáš</creatorcontrib><creatorcontrib>Žák, Pavel</creatorcontrib><creatorcontrib>Jindra, Pavel</creatorcontrib><creatorcontrib>Svobodník, Adam</creatorcontrib><creatorcontrib>Štěpánová, Radka</creatorcontrib><creatorcontrib>Mayer, Jiří</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Leukemia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Žáčková, Daniela</au><au>Semerád, Lukáš</au><au>Faber, Edgar</au><au>Klamová, Hana</au><au>Stejskal, Lukáš</au><au>Bělohlávková, Petra</au><au>Karas, Michal</au><au>Cmunt, Eduard</au><au>Černá, Olga</au><au>Procházková, Jiřina</au><au>Čičátková, Petra</au><au>Kvetková, Anežka</au><au>Horňák, Tomáš</au><au>Skoumalová, Ivana</au><au>Srbová, Dana</au><au>Šálek, Cyril</au><au>Buffa, David</au><au>Voglová, Jaroslava</au><au>Jurček, Tomáš</au><au>Folta, Adam</au><au>Ježíšková, Ivana</au><au>Žižková, Hana</au><au>Machová Poláková, Kateřina</au><au>Papajík, Tomáš</au><au>Žák, Pavel</au><au>Jindra, Pavel</au><au>Svobodník, Adam</au><au>Štěpánová, Radka</au><au>Mayer, Jiří</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF</atitle><jtitle>Leukemia</jtitle><stitle>Leukemia</stitle><addtitle>Leukemia</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>38</volume><issue>4</issue><spage>893</spage><epage>897</epage><pages>893-897</pages><issn>0887-6924</issn><issn>1476-5551</issn><eissn>1476-5551</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>38472478</pmid><doi>10.1038/s41375-024-02215-9</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-8415-7069</orcidid><orcidid>https://orcid.org/0000-0002-7003-3372</orcidid><orcidid>https://orcid.org/0000-0003-0567-9887</orcidid><orcidid>https://orcid.org/0000-0001-9802-8148</orcidid><orcidid>https://orcid.org/0000-0002-0021-3247</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0887-6924 |
| ispartof | Leukemia, 2024-04, Vol.38 (4), p.893-897 |
| issn | 0887-6924 1476-5551 1476-5551 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10997522 |
| source | SpringerLink Journals - AutoHoldings |
| subjects | 692/699/1541/1990/283/1896 692/700/784 Cancer Research Chronic myeloid leukemia Critical Care Medicine Drug dosages Education Elementary schools Females Hematology Intensive Internal Medicine Kinases Letter Leukemia Medicine Medicine & Public Health Multivariate analysis Myeloid leukemia Oncology Remission (Medicine) Tyrosine Tyrosine kinase inhibitors |
| title | Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T16%3A56%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Why%20are%20not%20all%20eligible%20chronic%20myeloid%20leukemia%20patients%20willing%20to%20attempt%20tyrosine%20kinase%20inhibitor%20discontinuation?%20A%20Czech%20nationwide%20analysis%20related%20to%20the%20TKI%20stopping%20trial%20HALF&rft.jtitle=Leukemia&rft.au=%C5%BD%C3%A1%C4%8Dkov%C3%A1,%20Daniela&rft.date=2024-04-01&rft.volume=38&rft.issue=4&rft.spage=893&rft.epage=897&rft.pages=893-897&rft.issn=0887-6924&rft.eissn=1476-5551&rft_id=info:doi/10.1038/s41375-024-02215-9&rft_dat=%3Cproquest_pubme%3E2956681986%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3033746454&rft_id=info:pmid/38472478&rfr_iscdi=true |